Literature DB >> 21344821

Implementation of virtual patients in the training for occupational health in Latin America.

Katja Radon1, Denise Carvalho, Maria Julia Calvo, Stephanie Struempell, Veronica Herrera, Laura Wengenroth, Gudrun Kausel, Nella Marchetti, Daniel Segura Rojas, Paul Russ, Inga Hege.   

Abstract

Health professionals trained in occupational health are essential to reduce the burden of occupational accidents and diseases. However, training resources are limited globally. We aimed to promote occupational health and safety (OHS) using virtual patients (VPs) in Brazil, Chile, and Germany. Virtual patients were created in three Latin-American health centers. So-called "partner VPs" comparing the distinct health care systems were designed. Translation, adaptation to different medical and legal systems, expert review, implementation into under- and postgraduate teaching, and user evaluation were performed. Twelve VPs covering traditional and contemporary OHS issues are available in Spanish, Portuguese, and English. Overall, 2371 students used the VPs. The number of Latin American users who evaluated VP content and relevance for their professional career was statistically significantly higher than the number of German students. VPs are a feasible learning method for OHS in middle-income countries. Partner VPs seem to be useful for teaching global aspects.

Entities:  

Mesh:

Year:  2011        PMID: 21344821     DOI: 10.1179/107735211799031068

Source DB:  PubMed          Journal:  Int J Occup Environ Health        ISSN: 1077-3525


  2 in total

1.  Compulsory teaching of occupational health: impact on attitude of medical students in Brazil and Germany.

Authors:  Paul Russ; Stephanie Strümpell; Denise Carvalho; Sabrina Zander; Paul Smits; Dennis Nowak; Katja Radon
Journal:  Int Arch Occup Environ Health       Date:  2011-05-24       Impact factor: 3.015

2.  European pharmacy students' experience with virtual patient technology.

Authors:  Afonso Miguel Cavaco; Filipe Madeira
Journal:  Am J Pharm Educ       Date:  2012-08-10       Impact factor: 2.047

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.